Light Mode
$0.0304 ↓ -0.0092 (-23.22%) Trading Down from the previous close of $0.0396, and at the day’s high of $0.0304
-0.02 (-37.32%) / 6M
Momentum, market sentiment, and recent alerts
SIGY reads n/a: the 12-month move is -99.0%.
No alerts for SIGY in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 29, 2019 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.